3-year real world outcomes with benralizumab for severe eosinophilic asthma

被引：0
|
作者：
Palmer, H. [1 ]
Whitehurst, C. [2 ]
Hince, K. [2 ]
Khurana, S. [2 ]
Tavernier, G. [1 ]
Elsey, L. [2 ]
机构：
[1] Univ Manchester, Manchester, Lancs, England
[2] Manchester Univ NHS Fdn Trust, Manchester, Lancs, England
来源：
THORAX | 2023年 / 78卷 / SUPPL_4期
关键词：
D O I：
10.1136/thorax-2023-BTSabstracts.413
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
M24
引用
收藏
页码：A274 / A275
页数：2
相关论文
共 50 条
  • [1] REAL-WORLD 1 YEAR EFFECTIVENESS OF BENRALIZUMAB IN SEVERE EOSINOPHILIC ASTHMA
    Kavanagh, J.
    Roxas, C.
    Thomson, L.
    Fernandes, M.
    Green, L.
    d'Ancona, G.
    Dhariwal, J.
    Nanzer, A. M.
    Kent, B. D.
    Jackson, D. J.
    THORAX, 2019, 74 : A138 - A138
  • [2] Real-World Effectiveness of Benralizumab in Severe Eosinophilic Asthma
    Kavanagh, Joanne E.
    Hearn, Andrew P.
    Dhariwal, Jaideep
    d'Ancona, Grainne
    Douiri, Abdel
    Roxas, Cris
    Fernandes, Mariana
    Green, Linda
    Thomson, Louise
    Nanzer, Alexandra M.
    Kent, Brian D.
    Jackson, David J.
    CHEST, 2021, 159 (02) : 496 - 506
  • [3] Real-world benralizumab effectiveness in patients with severe eosinophilic asthma on a 3 year follow up.
    Lo Muzio, Giulia
    Calo, Olimpia
    Cisternino, Cecilia
    Scarano, Paola
    Sanna, Arianna
    De Filippis, Francesca
    Steffanina, Alessia
    Palange, Paolo
    Graziani, Elda
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [4] OUTCOMES WITH MEPOLIZUMAB AND BENRALIZUMAB IN SEVERE EOSINOPHILIC ASTHMA
    Elsey, L.
    Hince, K.
    Aspin, P.
    Pantin, C. T.
    Allen, D.
    Niven, R.
    Fowler, S. J.
    Tavernier, G.
    THORAX, 2021, 76 : A142 - A142
  • [5] Real-world clinical outcomes for patients in the UK with severe, atopic eosinophilic asthma treated with benralizumab
    Jackson, D. J.
    Dube, S.
    Morris, T.
    Burhan, H.
    Pfeffer, P.
    ALLERGY, 2020, 75 : 40 - 40
  • [6] Super-responder analysis and real-world one year effectiveness of benralizumab in severe eosinophilic asthma
    Kavanagh, Joanne
    Roxas, Cris
    Green, Linda
    Fernandes, Mariana
    Thomson, Louise
    Payne, Victoria
    Hearn, Andrew
    Kent, Brian D.
    D'Ancona, Grainne
    Dhariwal, Jaideep
    Nanzer, Alexandra M. A.
    Jackson, David J.
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [7] Overcoming Barriers to Remission in Severe Eosinophilic Asthma: Two-Year Real-World Data With Benralizumab
    Jackson, David J.
    Burhan, Hassan
    Rupani, Hitasha
    Pfeffer, Paul E.
    Clifton, Ian J.
    Faruqi, Shoaib
    Dhariwal, Jaideep
    Patel, Pujan
    Morris, Tamsin
    Lipworth, Joseph
    Watt, Michael
    Lupton, Charlotte
    Dube, Sabada
    Hickey, Joe
    Nanzer, Alexandra M.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2024, 54 (10): : 734 - 746
  • [8] Real-World Effectiveness Study of Benralizumab for Severe Eosinophilic Asthma: ZEPHYR 2
    Carstens, Donna
    Maselli, Diego J.
    Mu, Fan
    Cook, Erin E.
    Yang, Danni
    Young, Joshua A.
    Betts, Keith A.
    Genofre, Eduardo
    Chung, Yen
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2023, 11 (07): : 2150 - +
  • [9] Early response to benralizumab in severe, eosinophilic asthma: a real-world study in Switzerland
    Schuoler, Claudio
    Van Iperen, Peter
    Stolz, Daiana
    Charbonnier, Florian
    Bridevaux, Pierre-Olivier
    Jandus, Peter
    Fiechter, Rene
    Leuppi, Jorg D.
    Hauser, Thomas
    Pavlov, Nikolay
    Scherer, Thomas
    Huber, Michael
    Azzola, Andrea
    Piecyk, Andreas
    Rothe, Thomas
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [10] Real-World Experience with Benralizumab in Patients with Severe Eosinophilic Asthma: A Case Series
    Menzella, Francesco
    Bonavia, Marco
    Bonini, Matteo
    D'Amato, Maria
    Lombardo, Salvatore
    Murgia, Nicola
    Patella, Vincenzo
    Triggiani, Massimo
    Pelaia, Girolamo
    JOURNAL OF ASTHMA AND ALLERGY, 2021, 14 : 149 - 161
12345